The study also found that tetrahydrocurcumin downregulated COX-2, EGFR, p-ERK1/2, and p-AKT in CaSki tumor tissue; it is likely that this downregulation is a part of the overall mechanism of angiogenesis inhibition and tumor-volume reduction [75]. This evidence concerns the gene AKT1 and neoplasm.